OR WAIT null SECS
March 02, 2011
With a regulatory pathway for follow-on biologics, industry is wondering what FDA will do next.
INTERPHEX 2011 aims to address the industry's unique characteristics.
Many solid oral dosage forms do not dissolve at the correct place in the gastrointestinal tract for them to be absorbed into the bloodstream. Could magnets solve the problem?
February 24, 2011
Gilead to Acquire Calistoga; Bayer Healthcare Appoints Former Pfizer Exec; and More.
February 17, 2011
Company and People Notes: sanofi to Acquire Genzyme; Lilly Makes Senior Appointments; and More.
February 11, 2011
The way in which a suspension nasal spray product interacts with the body depends not only on the droplet size of the delivered droplet, but also on the particle size of the suspended API.
February 10, 2011
Pfizer Acquires Ferrosan's Consumer Health Business; Patheon Appoints Former Biogen Exec as CEO; and More.
February 03, 2011
Company and People Notes: Pfizer Completes King Tender Offer; Cook Pharmica Names VP of R&D and CSO; and More
February 02, 2011
Deep process characterization and "lab-on-a-chip" enable SMART bioprocess design.
Follow-ons were all the rage at this year's JP Morgan Healthcare Conference.